Opioid-linked hospitalizations rising fastest for women: study

June 21, 2017

(HealthDay)—Opioid-related hospitalizations among women in the United States increased far faster than among men between 2005 and 2014, a federal government report says.

Among women, hospitalizations involving opioid painkillers or heroin rose 75 percent, compared to 55 percent among men, according to the U.S. Agency for Healthcare Research and Quality (AHRQ).

The surge among women during that 10-year period meant that by 2014 males and females were being hospitalized at a similar rate—about 225 hospitalizations per 100,000 people.

"As the report makes clear, over the past decade, has affected both sexes and all age groups. The crisis, however, looks different in different places," AHRQ Director Gopal Khanna noted in an agency news release.

In 2014, hospitalization rates among women were highest in West Virginia, Maryland and Massachusetts, exceeding 350 per 100,000 people. Among men, the highest rates were in the District of Columbia, New York and Maryland, topping 440 hospitalizations per 100,000.

The lowest rates for men and women were in Iowa and Nebraska.

Men were more likely than to make opioid-related visits to emergency departments in 2014, but such visits rose sharply for both sexes between 2005 and 2014, the report said.

Affected varied from state to state, and in some places seniors were hit especially hard. For example, in California and 12 other states, the hospitalization rate was highest among people 65 and older.

But in all that provided data on opioid-related visits to emergency departments, the rate was highest among 25- to 44-year-olds.

Khanna said the findings can help providers, researchers and policymakers understand and address the needs of patients visiting the because of opioids.

Misuse of potent painkillers such as OxyContin (oxycodone) and Vicoprofen (hydrocodone/ibuprofen) sends 1,000 Americans to emergency rooms each day. Opioid-related overdose deaths have quadrupled since 1999, according to federal statistics.

Explore further: DEA puts quota on production of opioid painkillers

More information: The U.S. National Institute on Drug Abuse has more about opioids.

Related Stories

DEA puts quota on production of opioid painkillers

October 6, 2016
(HealthDay)—The U.S. Drug Enforcement Administration (DEA) says it has mandated significant cuts in the production of powerful prescription opioid painkillers.

Strategies implemented to cut opioid ODs, deaths in maryland

June 15, 2017
(HealthDay)—Strategies are being implemented to reduce opioid overdoses and deaths in Maryland, according to a report published by the American Medical Association (AMA).

Steep rise in births to U.S. women using opioids

January 17, 2017
(HealthDay)—Over a decade, there was a nearly fivefold increase in the number of babies born each year to American women who have used opioids, a federal government report says.

Study examines opioid use in patients with rheumatoid arthritis

June 21, 2017
A new analysis indicates that the use of opioid pain medications in older US rheumatoid arthritis patients peaked in 2010 and is now declining slightly. By 2014, 41% of rheumatoid arthritis patients were regular opioid users.

US opioid crisis at epidemic proportions

May 4, 2017
Many US communities are facing an epidemic of opioid and heroin abuse that is straining resources from police, to jails, to emergency medical personnel and treatment centers.

Americans favor treatment, not enforcement, to address opioid crisis

May 23, 2017
Many Americans have been directly touched by the opioid crisis—more than a quarter of Americans and more than a third of millennials, report knowing someone who has been addicted to opioids or prescription painkillers. ...

Recommended for you

Glucocorticoids offer long-term benefits for patients with Duchenne muscular dystrophy

November 22, 2017
Glucocorticoids, a class of steroid hormone medications often prescribed to patients with Duchenne muscular dystrophy (DMD), offer long-term benefits for this disease, including longer preservation of muscle strength and ...

Baby-boomers and millennials more afflicted by the opioid epidemic

November 21, 2017
Baby-boomers, those born between 1947 and 1964, experienced an excess risk of prescription opioid overdose death and heroin overdose death, according to latest research at Columbia University's Mailman School of Public Health. ...

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (1) Jun 21, 2017
Opioid addiction can be alleviated without withdrawal symptoms by providing the addict by mouth with 250mg of healthy adult male facial skin surface lipid pheromone. The liquid "face grease" pheromone evaporates off an airborne aversive sub-pheromone which causes distrust, suspicion, superstition, arrogance, stupidity, and jealousy. Artificial jealousy is ubiquitous among osculation partners of treated addicts. To avoid jealousy, isolate the treated patient for 40 days. Staff should always use supplied air respirators. Ventilate, ventilate, ventilate with oscillating fans at high speed to break up plumes of the airborne sub-pheromone. Freeze the skin surface lipid liquid pheromone in storage. Use fume hoods.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.